Unknown

Dataset Information

Prognostic efficacy of the RTN1 gene in patients with diffuse large B-cell lymphoma.


ABSTRACT: Gene expression profiling has been vastly used to extract the genes that can predict the clinical outcome in patients with diverse cancers, including diffuse large B-cell lymphoma (DLBCL). With the aid of bioinformatics and computational analysis on gene expression data, various prognostic gene signatures for DLBCL have been recently developed. The major drawback of the previous signatures is their inability to correctly predict survival in external data sets. In other words, they are not reproducible in other datasets. Hence, in this study, we sought to determine the gene(s) that can reproducibly and robustly predict survival in patients with DLBCL. Gene expression data were extracted from 7 datasets containing 1636 patients (GSE10846 [n = 420], GSE31312 [n = 470], GSE11318 [n = 203], GSE

SUBMITTER: Zamani-Ahmadmahmudi M 

PROVIDER: S-EPMC8548397 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature